iRhythm Holdings (IRTC) Capital Expenditures Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.22% |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn | 1,817.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,817.42% |
| Dec 31, 2025 | 71.29% |
| Sep 30, 2025 | -44.79% |
| Jun 30, 2025 | 305.97% |
| Mar 31, 2025 | -98.65% |
| Dec 31, 2024 | -83.03% |
| Sep 30, 2024 | 149,350.00% |
| Jun 30, 2024 | -14.75% |
| Mar 31, 2024 | 16.06% |
| Dec 31, 2023 | 278.66% |
| Sep 30, 2023 | -100.28% |
| Jun 30, 2023 | -151.40% |
| Mar 31, 2023 | 3,643.56% |
| Dec 31, 2022 | -588.15% |
| Sep 30, 2022 | -52.41% |
| Jun 30, 2022 | 173.16% |
| Mar 31, 2022 | -94.66% |
| Dec 31, 2021 | 95.64% |
| Sep 30, 2021 | 137.60% |
| Jun 30, 2021 | 171.57% |
| Mar 31, 2021 | 23.67% |
| Dec 31, 2020 | -79.99% |
| Sep 30, 2020 | 66.55% |
| Jun 30, 2020 | -38.94% |
| Mar 31, 2020 | 99.71% |
| Dec 31, 2019 | 691.49% |
| Sep 30, 2019 | 130.18% |
| Jun 30, 2019 | 219.50% |
| Mar 31, 2019 | 53.88% |
| Dec 31, 2018 | 63.89% |
| Sep 30, 2018 | 175.14% |
| Jun 30, 2018 | 18.18% |
| Mar 31, 2018 | -5.62% |
| Dec 31, 2017 | -3.29% |
| Sep 30, 2017 | -29.39% |
| Jun 30, 2017 | 130.73% |
| Mar 31, 2017 | 78.15% |
| Dec 31, 2016 | 256.82% |